Thurston Springer Miller Herd & Titak’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-28
Closed -$580 – 742
2026
Q2
$580 Hold
28
– – ﹤0.01% 1193
2026
Q1
$652 Hold
28
– – ﹤0.01% 1275
2025
Q4
$1.24K Buy
+28
New +$1.57K ﹤0.01% 1273
2025
Q3
– Sell
-28
Closed -$1.72K – 750
2025
Q2
$1.72K Hold
28
– – ﹤0.01% 1441
2025
Q1
$1.62K Hold
28
– – ﹤0.01% 1468
2024
Q4
$1.49K Hold
28
– – ﹤0.01% 1165
2024
Q3
$1.22K Hold
28
– – ﹤0.01% 1385
2024
Q2
$783 Buy
+28
New +$739 ﹤0.01% 1420

Other funds holding DOCS

Thurston Springer Miller Herd & Titak's DOCS Position: Q3 2026 in Review

Thurston Springer Miller Herd & Titak sold out of Doximity (DOCS) in Q3 2026, closing a stake of 28 shares — an estimated $580 sold.

Thurston Springer Miller Herd & Titak first reported a position in DOCS in Q2 2024 and held it in 8 quarters. The position peaked at $1.72K in Q2 2025. 343 funds tracked by Wall St. Rank hold DOCS as of Q3 2026.

  • Thurston Springer Miller Herd & Titak reported no remaining Doximity position as of Q3 2026 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 28 Doximity shares in Q3 2026, an estimated $580.
  • Thurston Springer Miller Herd & Titak first reported a position in Doximity in Q2 2024 and held it in 8 quarters.
  • Thurston Springer Miller Herd & Titak's Doximity position peaked at $1.72K in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Doximity as of Q3 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2026, filed 14 Oct 2026.